Skip to main content
OpenTrials

Clinical trial condition

Lennox Gastaut Syndrome

Explore clinical trials studying Lennox Gastaut Syndrome. Study availability and eligibility vary by location and protocol.

15 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Lennox Gastaut Syndrome trial results

Recruiting

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

NCT05374824

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • C.S. Mott Children's Hospital Ann Arbor, Michigan, United States
  • St. Louis Children's Hospital St Louis, Missouri, United States
  • Nationwide Children's Columbus, Ohio, United States
View Trial Details
Recruiting

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

NCT05066217

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UC Irvine Medical Center Orange, California, United States
  • UCI Center for Innovative Health Therapies Orange, California, United States
  • Nemours Children's Health Wilmington, Delaware, United States
View all 26 locations
View Trial Details
Recruiting

BMB-101 in Absence Epilepsy and DEE

NCT06401538

Conditions
Absence Epilepsy, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • The Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal Brisbane and Womans Hospital Herston, Queensland, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View Trial Details
Recruiting

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

NCT05219617

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Stanford University Hospital Palo Alto, California, United States
  • University of Florida Health Science Center Jacksonville, Florida, United States
  • AdventHealth Orlando, Florida, United States
  • Pediatric Epilepsy and Neurology Specialists Tampa, Florida, United States
View all 71 locations
View Trial Details
Active, not recruiting

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

NCT05044819

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +27 more
Locations
  • Clinical Trial Site Little Rock, Arkansas, United States
  • Clinical Trial Site Downey, California, United States
  • Clinical Trial Site Long Beach, California, United States
  • Clinical Trial Site Sacramento, California, United States
View all 26 locations
View Trial Details
Active, not recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

NCT05485831

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +25 more
Locations
  • Policlinico Sant'Orsola di Bologna Bologna, Italy
  • NPI AOU Mater Domini Università Magna Graecia Catanzaro, Italy
  • Università degli studi "G. D'annunzio" Chieti Chieti, Italy
  • Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica Florence, Italy
View all 18 locations
View Trial Details
Active, not recruiting

RNS System LGS Feasibility Study

NCT05339126

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

NCT03936777

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Ep0215 107 Tucson, Arizona, United States
  • Ep0215 144 Los Angeles, California, United States
  • Ep0215 108 San Diego, California, United States
  • Ep0215 101 San Francisco, California, United States
View all 71 locations
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

NCT03355209

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +5 more
Locations
  • Ep0214 107 Tucson, Arizona, United States
  • Ep0214 144 Los Angeles, California, United States
  • Ep0214 101 San Francisco, California, United States
  • Ep0214 103 Aurora, Colorado, United States
View all 72 locations
View Trial Details

Related conditions